Ameriprise Financial Inc Heron Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $9,344 - $17,339	-9,633 Reduced 3.35%	277,538 $285,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $72,819 - $188,936	-65,603 Reduced 18.6%	287,171 $333,000
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $151,200 - $325,432	100,133 Added 39.63%	352,774 $532,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $7,728 - $16,041	3,435 Added 1.38%	252,641 $631,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $24,017 - $48,485	-9,029 Reduced 3.5%	249,206 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $84,357 - $230,698	36,677 Added 16.55%	258,235 $720,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $118,828 - $255,110	25,665 Added 13.1%	221,558 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $236,421 - $356,756	28,314 Added 16.9%	195,893 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $416,808 - $617,190	41,146 Added 32.54%	167,579 $1.79 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $562,793 - $783,755	42,411 Added 50.48%	126,433 $1.96 Million
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $245,098 - $350,478	-16,915 Reduced 16.76%	84,022 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $71,793 - $108,795	-4,914 Reduced 4.64%	100,937 $2.14 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $423,455 - $550,461	-30,977 Reduced 22.64%	105,851 $1.57 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $475,185 - $936,843	-43,635 Reduced 24.18%	136,828 $2.01 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $606,679 - $1.46 Million	59,304 Added 48.95%	180,463 $2.12 Million
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $461,124 - $704,393	26,471 Added 27.96%	121,159 $2.85 Million
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $96,933 - $126,735	5,925 Added 6.68%	94,688 $1.75 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $176,799 - $273,815	-10,443 Reduced 10.53%	88,763 $1.65 Million
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $1.67 Million - $2.04 Million	-72,037 Reduced 42.07%	99,206 $2.42 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $1.98 Million - $2.88 Million	89,951 Added 110.65%	171,243 $4.44 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $416,670 - $567,365	13,889 Added 20.61%	81,292 $2.57 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $431,296 - $686,154	16,337 Added 31.99%	67,403 $2.62 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $941,146 - $1.47 Million	51,066 New	51,066 $1.41 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account